SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-14-000210
Filing Date
2014-12-11
Accepted
2014-12-11 09:26:13
Documents
2
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1106
2 telkdelistreason.txt EX-99.25 1486
  Complete submission text file 0001354457-14-000210.txt   4260
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 000-31265
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850
Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144
NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE